Horace Mann CEO sells 7,500 shares at $50.99

HORACE MANN EDUCATORS CORP (HMN) reports that President & CEO and director Marita Zuraitis sold 7,500 shares of common stock on September 1, 2026 in an open-market transaction under a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

HORACE MANN EDUCATORS CORP (HMN) reports that President & CEO and director Marita Zuraitis sold 7,500 shares of common stock on September 1, 2026 in an open-market transaction under a Rule 10b5-1 trading plan. The weighted average sale price was about $50.99 per share, and she now holds 299,629.305 shares directly, including 217,395.305 vested restricted stock units and 82,234 shares of common stock.

Insider Trade Summary 10b5-1

Net Seller: 7,500 shares

Net Sell 1 txn

Insider ZURAITIS MARITA

Role President & CEO

Sold 7,500 shs ($382K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3	7,500	$50.99	$382K

Holdings After Transaction: Common Stock — 299,629.305 shares (Direct)

Footnotes (3)

1. F1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.62 to $51.25.
3. F3. Represents 217,395.305 vested restricted stock units and 82,234 shares of Common Stock.

Key Figures

Shares sold: 7,500 shares Weighted average sale price: $50.99 per share Sale price range: $50.62–$51.25 per share +4 more

7 metrics

Shares sold 7,500 shares Open-market sale on September 1, 2026 by President & CEO

Weighted average sale price $50.99 per share Average price for the 7,500 shares sold

Sale price range $50.62–$51.25 per share Prices of multiple transactions comprising the sale

Shares held after transaction 299,629.305 shares Direct holdings of the CEO following the sale

Vested restricted stock units 217,395.305 units Portion of CEO’s post-transaction direct holdings

Common shares (non-RSU) held 82,234 shares Common stock portion of CEO’s direct holdings after sale

10b5-1 plan adoption date December 23, 2025 Date CEO adopted the Rule 10b5-1 trading plan used for this sale

Key Terms

Rule 10b5-1 trading plan, weighted average price, vested restricted stock units

3 terms

Rule 10b5-1 trading plan regulatory

"The sale reported ... was effected by a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported ... is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vested restricted stock units financial

"Represents 217,395.305 vested restricted stock units and 82,234 shares"

FAQ

What insider transaction did HMN report for President & CEO Marita Zuraitis?

HMN reported that President & CEO Marita Zuraitis sold 7,500 shares of common stock on September 1, 2026 in an open-market transaction, made pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025.

At what price were the 7,500 HMN shares sold by the CEO?

The filing states a weighted average price of $50.99 per share. The 7,500 shares were sold in multiple transactions at prices ranging from $50.62 to $51.25 per share.

How many HMN shares does the CEO hold after this reported sale?

After the reported sale, Marita Zuraitis directly holds 299,629.305 shares of Horace Mann common stock. This total includes 217,395.305 vested restricted stock units and 82,234 shares of common stock.

Was the HMN CEO’s stock sale made under a Rule 10b5-1 plan?

Yes. The filing explains that the sale was effected by a Rule 10b5-1 trading plan adopted by Marita Zuraitis on December 23, 2025, indicating the transactions were pre-arranged under that plan.

What type of security did the HMN Form 4 transaction involve?

The Form 4 transaction involved common stock of Horace Mann Educators Corp. The filing also notes that the CEO’s post-transaction holdings include both vested restricted stock units and regular shares of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 11:52 AM Accepted by SEC EDGAR 09/03/2026 - 11:52 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZURAITIS MARITA

(Last) (First) (Middle)

1 HORACE MANN PLAZA

(Street)

SPRINGFIELD ILLINOIS 62715

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HORACE MANN EDUCATORS CORP /DE/ [ HMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	09/01/2026		S		7,500	D	$50.99(2)	299,629.305(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.62 to $51.25.

3. Represents 217,395.305 vested restricted stock units and 82,234 shares of Common Stock.

Remarks:

	Linea K. Crouse, Attorney in Fact for Marita Zuraitis	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)